97 Machine learning algorithms in the prognosis of cutaneous melanoma: a population-based study
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed an accurate machine learning model to predict cutaneous melanoma prognosis using a large dataset. The best model identified key prognostic factors for improved patient outcomes.
Area Of Science
- Oncology
- Computational Biology
- Biostatistics
Background
- Cutaneous melanoma prognosis prediction is crucial for patient management.
- Machine learning offers potential for developing robust predictive models.
Purpose Of The Study
- To establish a predictive model for cutaneous melanoma prognosis.
- Utilize machine learning algorithms on large-scale data for enhanced accuracy.
Main Methods
- Retrospective analysis of SEER database (2010-2015).
- Evaluated 97 machine learning algorithm combinations.
- Identified key prognostic variables for model development.
Main Results
- 24,457 cases analyzed, 8,441 included (5908 training, 2533 testing).
- StepCox + RSF identified as the optimal predictive model.
- Key predictors include Sex, Age, T stage, N stage, metastasis, and treatment variables.
Conclusions
- A highly accurate predictive model for cutaneous melanoma prognosis was developed.
- The model leverages machine learning on extensive patient data.
- Identified significant prognostic factors can aid clinical decision-making.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...